Entry Point Capital, LLC Geron Corp Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Geron Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 49,263 shares of GERN stock, worth $165,031. This represents 0.13% of its overall portfolio holdings.
Number of Shares
49,263Holding current value
$165,031% of portfolio
0.13%Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
274Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$156 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$148 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$109 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$108 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$97 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.27B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...